Showing results (621-630 of 939) with videos related to
Sort By:
Pageof 94
Diabetic Medicine : a Journal of the British Diabetic Association|November 14, 2012
Care of children with diabetes as inpatients: frequency of admissions, clinical care and patient experienceJ A Edge, F Ackland, S Payne, et al.Palliative Medicine|March 24, 2009
Supporting lay carers in end of life care: current gaps and future prioritiesG Grande, K Stajduhar, S Aoun, et al.Annals of Plastic Surgery|July 1, 2026
The Rise of Nerve Transfers: Tracing a National Evolution Toward the Postgrafting Era in Brachial Plexus Injury ManagementPooja Dhupati, Jonathan Jeger, Sunny Vansdadia, et al.Alcoholism, Clinical and Experimental Research|August 16, 2001
Effects of abstinence from alcohol on the broad phospholipid signal in human brain: an in vivo 31P magnetic resonance spectroscopy studyM R Estilaei, G B Matson, G S Payne, et al.The Biochemical Journal|July 22, 2008
Mapping of the ATP-binding domain of human fructosamine 3-kinase-related protein by affinity labelling with 5'-[p-(fluorosulfonyl)benzoyl]adenosineLeo S Payne, Peter M Brown, Martin Middleditch, et al.The Annals of Thoracic Surgery|August 1, 1979
Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patientsN Okike, W S Payne, D M Neufeld, et al.Journal of Medical Screening|March 11, 2015
The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmesL Mead, L Porteous, M Tait, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1990
Sites of action of ondansetron to inhibit withdrawal from drugs of abuseB Costall, B J Jones, M E Kelly, et al.Pharmacology, Biochemistry, and Behavior|June 1, 1990
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuseB Costall, B J Jones, M E Kelly, et al.Behavioural Brain Research|January 1, 1996
Species differences in 5-HT autoreceptorsG W Price, C Roberts, J Watson, et al.Pageof 94